Please Wait
Applying Filters...
menu
    • menu

    List of Written Confirmation(s) issued for Meropenem Active Pharmaceutical Ingredient (API)

    Client Email Product
    US, Europe turn to advanced manufacturing, stockpiling to strengthen drug supply chains

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Sept 2024: BMS wins landmark FDA approval for schizophrenia med; Sanofi’s Dupixent okayed for COPD

    Stock Recap
    #PipelineProspector

    Menu

    Meropenem

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,000Xls download

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Name of the Firm Written Confirmation No. Product Name Issue Date Valid Till Address of the Firm
    13/04/2020 Kopran
    India
    		 Kopran Research Laboratories Limited WC-0090 Meropenem For Injection USP 2022-08-31 2025-07-14 K4/4, Additional MIDC, Bivwadi, Taluk Mahad, Dist Raigad-402302, Maharashtra, India
    20/04/2020 Rajasthan Antibiotics
    India
    		 Rajasthan Antibiotics Ltd WC-0420-A Meropenem USP (Sterile) 2018-12-05 2021-04-01 A-619 & 630, RIICO Ind. Area, Bhiwadi-301 019, Dist. Alwar, Rajasthan